MET基因改变的非小细胞肺癌靶向治疗耐药机制及治疗策略

间质表皮转化因子(mesenchymal to epithelial transition factor,MET)基因改变参与了非小细胞肺癌的增殖、侵袭和转移.MET-酪氨酸激酶抑制剂(tyrosine kinase inhibitors,TKIs)已获批用于MET基因改变的非小细胞肺癌,而这些药物的耐药不可避免.MET-TKIs的分子耐药机制错综复杂,尚不完全清楚.本文主要对这些MET-TKIs的潜在耐药机制进行综述,以期为MET基因改变的患者提供合理的治疗思路....

Full description

Saved in:
Bibliographic Details
Published in:中国肺癌杂志 Vol. 26; no. 9; pp. 684 - 691
Main Authors: 李舒展, 张新伟
Format: Journal Article
Language:Chinese
Published: 300060 天津,天津医科大学肿瘤医院生物治疗科,国家恶性肿瘤临床医学研究中心,天津市"肿瘤防治"重点实验室,天津市恶性肿瘤临床医学研究中心,天津市肿瘤免疫与生物治疗重点实验室 2023
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract 间质表皮转化因子(mesenchymal to epithelial transition factor,MET)基因改变参与了非小细胞肺癌的增殖、侵袭和转移.MET-酪氨酸激酶抑制剂(tyrosine kinase inhibitors,TKIs)已获批用于MET基因改变的非小细胞肺癌,而这些药物的耐药不可避免.MET-TKIs的分子耐药机制错综复杂,尚不完全清楚.本文主要对这些MET-TKIs的潜在耐药机制进行综述,以期为MET基因改变的患者提供合理的治疗思路.
AbstractList 间质表皮转化因子(mesenchymal to epithelial transition factor,MET)基因改变参与了非小细胞肺癌的增殖、侵袭和转移.MET-酪氨酸激酶抑制剂(tyrosine kinase inhibitors,TKIs)已获批用于MET基因改变的非小细胞肺癌,而这些药物的耐药不可避免.MET-TKIs的分子耐药机制错综复杂,尚不完全清楚.本文主要对这些MET-TKIs的潜在耐药机制进行综述,以期为MET基因改变的患者提供合理的治疗思路.
Author 李舒展
张新伟
AuthorAffiliation 300060 天津,天津医科大学肿瘤医院生物治疗科,国家恶性肿瘤临床医学研究中心,天津市"肿瘤防治"重点实验室,天津市恶性肿瘤临床医学研究中心,天津市肿瘤免疫与生物治疗重点实验室
AuthorAffiliation_xml – name: 300060 天津,天津医科大学肿瘤医院生物治疗科,国家恶性肿瘤临床医学研究中心,天津市"肿瘤防治"重点实验室,天津市恶性肿瘤临床医学研究中心,天津市肿瘤免疫与生物治疗重点实验室
Author_FL Xinwei ZHANG
Shuzhan LI
Author_FL_xml – sequence: 1
  fullname: Shuzhan LI
– sequence: 2
  fullname: Xinwei ZHANG
Author_xml – sequence: 1
  fullname: 李舒展
– sequence: 2
  fullname: 张新伟
BookMark eNrjYmDJy89LZWBQMTTQMzY3t9TP0sssLs7TMzQwsNQ1NjG01DMyMDIGco30jI1ZGDjh4hwMvMXFmUkGBkZGZkaWBqacDN6-riFP5-96OnvBsyk7n_bPeD6r5eXceU839D_f3faied6Lpl3PZ_a8nLvt6YSJzzbtfj5t-ouGCS961z-bs-tpx7an_V0Qwedrpz2fupSHgTUtMac4lRdKczOou7mGOHvolifmpSXmpcdn5ZcW5QFl4qvS0xKrqkCONLA0MDA1Jl4lAB_5Yt0
ContentType Journal Article
Copyright Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2B.
4A8
92I
93N
PSX
TCJ
DOI 10.3779/j.issn.1009-3419.2023.102.33
DatabaseName Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitle_FL Drug Resistance Mechanism and Therapeutic Strategy of Targeted Therapy of Non-small Cell Lung Cancer with MET Alterations
EndPage 691
ExternalDocumentID zgfazz202309005
GroupedDBID ---
-05
04C
29R
2B.
2WC
3V.
4A8
5GY
5VS
6PF
92F
92I
93N
AAWTL
ABUWG
ACGFS
AFKRA
ALMA_UNASSIGNED_HOLDINGS
BENPR
BPHCQ
BVBZV
C1A
CCEZO
CCPQU
CIEJG
CW9
DIK
E3Z
EBD
EIHBH
EMOBN
EOJEC
F5P
GROUPED_DOAJ
HYE
IPNFZ
KQ8
KWQ
OBODZ
OK1
PGMZT
PIMPY
PQQKQ
PROAC
PSX
RIG
RNS
RPM
TCJ
TGQ
U1G
U5O
ID FETCH-wanfang_journals_zgfazz2023090053
ISSN 1009-3419
IngestDate Wed Nov 06 04:35:53 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Treatment strategy
靶向治疗
Targeted therapy
间质表皮转化因子
肺肿瘤
Drug resistance
Mesenchymal to epithelial transition factor
治疗策略
耐药
Lung neoplasms
Language Chinese
LinkModel OpenURL
MergedId FETCHMERGED-wanfang_journals_zgfazz2023090053
ParticipantIDs wanfang_journals_zgfazz202309005
PublicationCentury 2000
PublicationDate 2023
PublicationDateYYYYMMDD 2023-01-01
PublicationDate_xml – year: 2023
  text: 2023
PublicationDecade 2020
PublicationTitle 中国肺癌杂志
PublicationTitle_FL Chinese Journal of Lung Cancer
PublicationYear 2023
Publisher 300060 天津,天津医科大学肿瘤医院生物治疗科,国家恶性肿瘤临床医学研究中心,天津市"肿瘤防治"重点实验室,天津市恶性肿瘤临床医学研究中心,天津市肿瘤免疫与生物治疗重点实验室
Publisher_xml – name: 300060 天津,天津医科大学肿瘤医院生物治疗科,国家恶性肿瘤临床医学研究中心,天津市"肿瘤防治"重点实验室,天津市恶性肿瘤临床医学研究中心,天津市肿瘤免疫与生物治疗重点实验室
SSID ssib002262905
ssib001103766
ssj0062934
ssib044765436
ssib038074678
ssib051369142
Score 4.742362
Snippet 间质表皮转化因子(mesenchymal to epithelial transition factor,MET)基因改变参与了非小细胞肺癌的增殖、侵袭和转移.MET-酪氨酸激酶抑制剂(tyrosine kinase...
SourceID wanfang
SourceType Aggregation Database
StartPage 684
Title MET基因改变的非小细胞肺癌靶向治疗耐药机制及治疗策略
URI https://d.wanfangdata.com.cn/periodical/zgfazz202309005
Volume 26
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwzR27bhNBcBUSKaJBPMUzSpERBXKwz3t3u-WefVZQFBpS0EW52AmVkQhpXCFACCFQggThmUBDiUAUkUi-52znL5iZXZ9PicmjQKKxRrMzO6_17uzd7awQE4tS1un9UMFPGsWC9OteIVFeWMCh4-OUidsxPiE3dSe8fVdVYxkPjfTuqOvj_mmkEYexppOzx4h21ikiEMaY4y9GHX-PFPeZeBZiH3QNIsNABKYIcQBaQqQJo2qgFcQhaANKQqxBV0HH1BQVqRWboghUALECVeYmBDzuELk0qIrjigIWUQRdIhGRR4xEg-JC5qLvKBiogqmxGhWnmFKOHSUqM4g9BFMlmDA-GD-fSEOM5igisDZG1UFKBqQkIsk0tDpbc3st1jIF2pKUwF7FaUkQUen5LiDXkMgKejb_pMQeY-ZRXeayMzeI0Ugwmk1CwMdhPABJllecwSZkD1qakAH0V9AziUOCMcPWPpcmI43HTZLijYDSPRH7XckirCbOXygl5hgEuJ_oAUVWYL9cdnfECqCLlclpkmkbkrtQGQI0d5gLEvaGg-lvrohYoucNEq0JQIsyu4gMAxzSqCKrPTey0RwarOgEw-FnDPZwsND_x_zB4fadmRhKE7k-aeQeJe7H8FIuPaFXmVSBMZ-_2IoTbp7WuWQksJcvurw2sLfi7U2ZqOAop0wkYDITMEl_IKrrMmnr1OwpSt9aWpxvtYgGp3MqIT3i4UJPN8hUb033t2N0CDn_eMgLPN3PL-iuC8zTsvVfypBOumf0uFig0jIrB4jM9iuhnpKjYsJZcPMg_fk8ZnNxvrmU2zrMnhan3J5_3NjJ-owYat07K0Zn3FdN58Q0ztnpl-3009f2m9_p6vvOx6e7G5vpz9XOzrPuk83u4-3Oh5e7G1vp2uv2r53O-rvuo7Xuqx_tz9vp86109YVFdr6vd95-Oy-u1-LZylTB6TLnFo3luT3OLF8Qw837zcZFMR7WS40k9BvJgqI1tZR4iV-WxaThy2Qh0PKSGD-st8uHk1wRJwm2D5aviuGHD1Ya18SJ5frKGMdzjB9U_gHggAwh
link.rule.ids 315,782,786,866,4028,27932,27933,27934
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MET%E5%9F%BA%E5%9B%A0%E6%94%B9%E5%8F%98%E7%9A%84%E9%9D%9E%E5%B0%8F%E7%BB%86%E8%83%9E%E8%82%BA%E7%99%8C%E9%9D%B6%E5%90%91%E6%B2%BB%E7%96%97%E8%80%90%E8%8D%AF%E6%9C%BA%E5%88%B6%E5%8F%8A%E6%B2%BB%E7%96%97%E7%AD%96%E7%95%A5&rft.jtitle=%E4%B8%AD%E5%9B%BD%E8%82%BA%E7%99%8C%E6%9D%82%E5%BF%97&rft.au=%E6%9D%8E%E8%88%92%E5%B1%95&rft.au=%E5%BC%A0%E6%96%B0%E4%BC%9F&rft.date=2023&rft.pub=300060+%E5%A4%A9%E6%B4%A5%2C%E5%A4%A9%E6%B4%A5%E5%8C%BB%E7%A7%91%E5%A4%A7%E5%AD%A6%E8%82%BF%E7%98%A4%E5%8C%BB%E9%99%A2%E7%94%9F%E7%89%A9%E6%B2%BB%E7%96%97%E7%A7%91%2C%E5%9B%BD%E5%AE%B6%E6%81%B6%E6%80%A7%E8%82%BF%E7%98%A4%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83%2C%E5%A4%A9%E6%B4%A5%E5%B8%82%22%E8%82%BF%E7%98%A4%E9%98%B2%E6%B2%BB%22%E9%87%8D%E7%82%B9%E5%AE%9E%E9%AA%8C%E5%AE%A4%2C%E5%A4%A9%E6%B4%A5%E5%B8%82%E6%81%B6%E6%80%A7%E8%82%BF%E7%98%A4%E4%B8%B4%E5%BA%8A%E5%8C%BB%E5%AD%A6%E7%A0%94%E7%A9%B6%E4%B8%AD%E5%BF%83%2C%E5%A4%A9%E6%B4%A5%E5%B8%82%E8%82%BF%E7%98%A4%E5%85%8D%E7%96%AB%E4%B8%8E%E7%94%9F%E7%89%A9%E6%B2%BB%E7%96%97%E9%87%8D%E7%82%B9%E5%AE%9E%E9%AA%8C%E5%AE%A4&rft.issn=1009-3419&rft.volume=26&rft.issue=9&rft.spage=684&rft.epage=691&rft_id=info:doi/10.3779%2Fj.issn.1009-3419.2023.102.33&rft.externalDocID=zgfazz202309005
thumbnail_s http://sdu.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fzgfazz%2Fzgfazz.jpg